SCHEMBL24980950

SCHEMBL24980950

Cc1cccc(-c2cc(Cl)cc(C)c2C)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.39
TRPA1 O75762 1/20 0.37
ATM Q13315 1/20 0.37
CHEK1 O14757 1/20 0.36
WEE1 P30291 1/20 0.36
NUDT1 P36639 3/20 0.36
CES1 P23141 1/20 0.35
CNR2 P34972 1/20 0.34
SCN4A P35499 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PBRM1 Q86U86 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
IDH1 O75874 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SENP8 Q96LD8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8116405 0.85 CNR1 (0.35) CNR1TRPA1ATMCHEK1WEE1
SCHEMBL13651415 0.80 CYP1A1 (0.38) CNR1TRPA1ATMCHEK1WEE1
SCHEMBL30834716 0.79 TRPA1 (0.52) CNR1TRPA1ATMNUDT1CNR2
SCHEMBL218508 0.79 TRPA1 (0.52) CNR1TRPA1ATMNUDT1CNR2
Ammonia Solution, Strong SCHEMBL15862222 0.77 TRPA1 (0.50) CNR1TRPA1ATMNUDT1CNR2
Ammonia Solution, Strong SCHEMBL22444763 0.77 TRPA1 (0.50) CNR1TRPA1ATMNUDT1CNR2
Hydrogen Sulfide SCHEMBL1538405 0.77 TRPA1 (0.50) CNR1TRPA1ATMNUDT1CNR2
SCHEMBL28434186 0.76 ESR2 (0.49) CNR1ALDH1A1GAACYP1A2
SCHEMBL23198745 0.76 TRPA1 (0.41) CNR1TRPA1ATMNUDT1CNR2
SCHEMBL19838629 0.74 TRPA1 (0.48) CNR1TRPA1ATMNUDT1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4122537-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Gilead Sciences, Inc. (US) 2023-01-25 EP disclosed